Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281619 · ClinicalTrials.gov registry record
PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 29
- Enrollment target
NCT00281619: Completed study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT00281619 is a clinical trial that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00281619 has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how fast children, who have had a recent kidney transplant, absorb, breakdown and eliminate mycophenolic acid (CellCept) following their prescribed dose. The results may lead to better dosing based on individual needs.
Interventions
- BEHAVIORAL Dietary Monitoring
- PROCEDURE Blood Sampling
- DRUG CellCept (mycophenolate mofetil)
- BEHAVIORAL Drug Diary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-02 |
What the finished NCT00281619 record still lists
NCT00281619 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Dietary Monitoring is the first listed.
NCT00281619 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00281619 about?
NCT00281619 is a clinical study titled "PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients". The purpose of this study is to determine how fast children, who have had a recent kidney transplant, absorb, breakdown and eliminate mycophenolic acid (CellCept) following their prescribed dose. The results may lead to better dosing based on individual needs.
What is the current status of trial NCT00281619?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2006-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00281619?
The interventions under investigation include: Dietary Monitoring (BEHAVIORAL), Blood Sampling (PROCEDURE), CellCept (mycophenolate mofetil) (DRUG), Drug Diary (BEHAVIORAL).
Who is sponsoring clinical trial NCT00281619?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia